Comparing Metabolic Outcomes Associated with Aripiprazole and Olanzapine in Schizophrenia Spectrum Disorder: Insights from a Large Real-World Cohort Using TriNetX
Comparing Metabolic Outcomes Associated with Aripiprazole and Olanzapine in Schizophrenia Spectrum Disorder: Insights from a Large Real-World Cohort Using TriNetX